Nitric oxide (NO) can play an important role in the regulation of vascular
tone and neurotransmission, as well as in non-specific immunoreactions and
inflammation in a variety of tissues. Increased quantities of nitric oxide
in respired air can be measured during inflammatory processes. However, the
exact role and precise sources of NO under physiological and pathophysiolo
gical conditions within the airways remain to be defined.
Three isoforms of NO-synthases can be distinguished:two constitutive (neuro
nal and endothelial) Ca2+-dependent cNOS and one inducible Ca2+-independent
iNOS (NOS II). Constitutive NOS (NOS I and III) release a basal amount of
NO under physiological conditions. The inducible form once expressed can ca
talyse the generation of large quantities of NO. Many kinds of cells,such a
s macrophages, neutrophils, endothelium and smooth muscle cells, are capabl
e of expressing NOS II.
Since all isoforms of NO-synthase seem to be present in nasal tissues and t
he expression of iNOS under inflammatory conditions seems to be responsible
for excessive production of NO,the distribution of NOS-isoforms (especiall
y NOS II) in normal and inflammatory nasal tissue, as well as the exact req
uirements for expression of iNOS remain to be proven.
Non-inflamed fresh human nasal mucosa from the middle turbinate was compare
d immuno-histologically with nasal mucosa having the typical findings of ch
ronic polypoid rhinosinusitis (i.e., polypoid middle turbinates and polyps
of the middle nasal duct). In order to gain more information about the mech
anisms of acute inflammation, non-inflamed vital turbinates were incubated
in vitro with the proinflammatory substances bacterial lipopolysaccharides
(LPS) and tumor necrosis-factor (TNF) for 30, 60, 90, 120, 180 and 240 min.
Subsequent to exposure to NADPH-diaphorase and immunostaining with specifi
c antibodies to each NOS-isoform, clearly increased or initiated expression
s of inducible NOS (iNOS) in blood vessels, glands, macrophages and epithel
ium of chronically inflamed and LPS-incubated nasal tissue became apparent
in comparison to the non-inflamed controls. In contrast, NOS III/NOS I seem
ed to be not affected. The onset of immunohistochemically recognizable NOS
II expression was observed after 90 min incubation with of LPS/TNF-alpha. P
olypoid tissue showed a strong increase in submucosal thickness and a high
infiltration of iNOS-positive leukocytes (granulocytes and macrophages) com
pared to the LPS-incubated non-inflamed specimens. These findings implicate
NOS II generated nitric oxide as a key agent for causing swelling, secreti
on and obstruction in patients with acute and chronic polypoid or allergic
rhinitis. These findings also suggest that molecular NO has to be considere
d in the pathophysiology of chronic polypoid rhinosinusitis.